Thomas Kolben

1.6k total citations
102 papers, 975 citations indexed

About

Thomas Kolben is a scholar working on Immunology, Molecular Biology and Obstetrics and Gynecology. According to data from OpenAlex, Thomas Kolben has authored 102 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 27 papers in Molecular Biology and 21 papers in Obstetrics and Gynecology. Recurrent topics in Thomas Kolben's work include Reproductive System and Pregnancy (18 papers), Pregnancy and preeclampsia studies (12 papers) and Galectins and Cancer Biology (11 papers). Thomas Kolben is often cited by papers focused on Reproductive System and Pregnancy (18 papers), Pregnancy and preeclampsia studies (12 papers) and Galectins and Cancer Biology (11 papers). Thomas Kolben collaborates with scholars based in Germany, Austria and Switzerland. Thomas Kolben's co-authors include Udo Jeschke, Sven� Mahner, Elisa Schmoeckel, Christina Kühn, T Kolben, Anna Hester, Susanne Beyer, Bastian Czogalla, Sarah Meister and Doris Mayr and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Thomas Kolben

97 papers receiving 966 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Kolben Germany 17 286 270 189 140 139 102 975
Xin Luo China 22 379 1.3× 211 0.8× 399 2.1× 104 0.7× 276 2.0× 49 1.0k
Yanhong Yu China 20 472 1.7× 189 0.7× 434 2.3× 254 1.8× 245 1.8× 46 1.6k
Emmanuel N. Kontomanolis Greece 19 574 2.0× 164 0.6× 164 0.9× 257 1.8× 347 2.5× 80 1.2k
Julia Gallwas Germany 20 201 0.7× 80 0.3× 71 0.4× 179 1.3× 87 0.6× 77 1.2k
Bihong Zhao United States 17 316 1.1× 218 0.8× 62 0.3× 248 1.8× 66 0.5× 61 1.2k
Radek Kučera Czechia 19 281 1.0× 105 0.4× 63 0.3× 309 2.2× 204 1.5× 94 1.0k
Wentao Yue China 22 549 1.9× 147 0.5× 89 0.5× 305 2.2× 189 1.4× 114 1.4k
Adi Shani Israel 20 300 1.0× 133 0.5× 73 0.4× 353 2.5× 118 0.8× 88 1.3k
Naoko Sasamoto United States 12 117 0.4× 113 0.4× 175 0.9× 163 1.2× 67 0.5× 56 725

Countries citing papers authored by Thomas Kolben

Since Specialization
Citations

This map shows the geographic impact of Thomas Kolben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kolben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kolben more than expected).

Fields of papers citing papers by Thomas Kolben

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Kolben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kolben. The network helps show where Thomas Kolben may publish in the future.

Co-authorship network of co-authors of Thomas Kolben

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Kolben. A scholar is included among the top collaborators of Thomas Kolben based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Kolben. Thomas Kolben is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hermelink, Kerstin, et al.. (2025). Influence of breast cancer on life satisfaction in the elderly patient. Archives of Gynecology and Obstetrics. 311(4). 1163–1171.
2.
Hertlein, Linda, et al.. (2025). Vaginal Breech Birth: Learnings from 21 Years of Retrospective Data Analysis. Geburtshilfe und Frauenheilkunde. 85(11). 1150–1168.
3.
Ciotkowska, Anna, Beata Rutz, Heiko Schulz, et al.. (2024). Immunomodulatory imide drugs inhibit human detrusor smooth muscle contraction and growth of human detrusor smooth muscle cells, and exhibit vaso-regulatory functions. Biomedicine & Pharmacotherapy. 177. 117066–117066. 1 indexed citations
4.
Kolben, Thomas, Carolin Perleberg, Sarah Meister, et al.. (2024). CCL22 as an independent prognostic factor in endometrial cancer patients. Translational Oncology. 50. 102116–102116. 1 indexed citations
5.
Rohwedder, Ina, Claudia Nußbaum, Melanie Salvermoser, et al.. (2023). A20 and the noncanonical NF-κB pathway are key regulators of neutrophil recruitment during fetal ontogeny. JCI Insight. 8(4). 7 indexed citations
6.
Meister, Sarah, Susanne Beyer, Carolin Perleberg, et al.. (2022). Regulatory T Cell Apoptosis during Preeclampsia May Be Prevented by Gal-2. International Journal of Molecular Sciences. 23(3). 1880–1880. 12 indexed citations
7.
Meister, Sarah, Susanne Beyer, Stefanie Corradini, et al.. (2022). Gal-2 Increases H3K4me3 and H3K9ac in Trophoblasts and Preeclampsia. Biomolecules. 12(5). 707–707. 7 indexed citations
8.
Kolben, Thomas, Mirjana Kessler, Sarah Meister, et al.. (2022). FAM111A Is a Novel Molecular Marker for Oocyte Aging. Biomedicines. 10(2). 257–257. 1 indexed citations
9.
Kolben, Thomas, Carolin Perleberg, David Anz, et al.. (2022). Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells. Cellular Oncology. 45(6). 1171–1185. 11 indexed citations
10.
Huber, Marinus, Kosmas V. Kepesidis, Frank Fleischmann, et al.. (2021). Infrared molecular fingerprinting of blood-based liquid biopsies for the detection of cancer. eLife. 10. 26 indexed citations
11.
Kaltofen, Till, Doris Mayr, Elisa Schmoeckel, et al.. (2021). Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer as a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway. Biomedicines. 9(7). 706–706. 6 indexed citations
12.
Meister, Sarah, Susanne Beyer, Stefanie Corradini, et al.. (2021). Epigenetic changes occur in placentas of spontaneous and recurrent miscarriages. Journal of Reproductive Immunology. 149. 103466–103466. 8 indexed citations
13.
Kolben, Thomas, Sarah Meister, Christina Kühn, et al.. (2021). Factors Influencing the In Vitro Maturation (IVM) of Human Oocyte. Biomedicines. 9(12). 1904–1904. 25 indexed citations
14.
Meister, Sarah, Susanne Beyer, Christina Kühn, et al.. (2021). Epigenetic modification via H3K4me3 and H3K9ac in human placenta is reduced in preeclampsia. Journal of Reproductive Immunology. 145. 103287–103287. 12 indexed citations
15.
Kühn, Christina, Thomas Kolben, Zhi Ma, et al.. (2020). Early Life Oxidative Stress and Long-Lasting Cardiovascular Effects on Offspring Conceived by Assisted Reproductive Technologies: A Review. International Journal of Molecular Sciences. 21(15). 5175–5175. 23 indexed citations
16.
Heublein, Sabine, Doris Mayr, Anna Reischer, et al.. (2020). M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis. Cells. 9(5). 1224–1224. 26 indexed citations
17.
Czogalla, Bastian, Doris Mayr, Elisa Schmoeckel, et al.. (2019). <p>Correlation of NRF2 and progesterone receptor and its effects on ovarian cancer biology</p>. Cancer Management and Research. Volume 11. 7673–7684. 14 indexed citations
18.
Hester, Anna, Martina Rahmeh, Thomas Kolben, et al.. (2019). <p>EP3 receptor antagonist L798,106 reduces proliferation and migration of SK-BR-3 breast cancer cells</p>. OncoTargets and Therapy. Volume 12. 6053–6068. 13 indexed citations
19.
Kolben, Thomas, Udo Jeschke, Toralf Reimer, et al.. (2017). Induction of apoptosis in breast cancer cells in vitro by Fas ligand reverse signaling. Journal of Cancer Research and Clinical Oncology. 144(2). 249–256. 14 indexed citations
20.
Kolben, Thomas, Doris Augustin, Robert Armbrust, et al.. (2015). Impact of guideline-based use of uPA/PAI-1 on patient outcome in intermediate-risk early breast cancer. Breast Cancer Research and Treatment. 155(1). 109–115. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xin Luo Breakdown of academic impact, for papers by Yanhong Yu Breakdown of academic impact, for papers by Emmanuel N. Kontomanolis Breakdown of academic impact, for papers by Julia Gallwas Breakdown of academic impact, for papers by Bihong Zhao Breakdown of academic impact, for papers by Radek Kučera Breakdown of academic impact, for papers by Wentao Yue Breakdown of academic impact, for papers by Adi Shani Breakdown of academic impact, for papers by Naoko Sasamoto
Rankless by CCL
2026